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Sensing of invading DNA virus genomes appear to be triggered by a number of host cell DNA sensors depending 
on their subcellular localization which stimulate innate anti-viral responses such as the induction of type-I 
interferons (IFNs) and/or activation of inflammasomes resulting in the production of inflammatory IL-1β and 
IL-18 cytokines. With growing understanding of diverse identities whether these proteins function alone or with 
other host cell molecules and the post-translational modifications affecting their functions are under intense 
investigations. Nuclear resident IFI16 have been shown to sense the episomal DNA genomes of herpes viruses 
resulting in the induction of IFI16-inflammasome and/or interferon responses. Here, we highlight our recent 
finding regarding the role of cellular BRCA1, a transcription factor and DNA damage response protein, forming 
a distinct complex with IFI16 to regulate the nuclear innate sensing of herpes viral DNA and subsequent 
IFI16-ASC-procaspase-1 inflammasome complex formation and distribution to the cytoplasm leading into 
caspase-1 and IL-1β production. BRCA1 is also responsible for the cytoplasmic IFI16-STING signalosome 
activation and induction of IFN-β during de novo KSHV and HSV-1 infection. Our concurrent studies have also 
revealed that the histone acetyl transferase p300 mediated acetylation of nuclear IFI16 is a dynamic post-genome 
recognition event responsible for Ran dependent nuclear to cytoplasmic trafficking of IFI16 during herpesvirus 
infection. This post-translational modification is essential for IFI16-ASC interaction and inflammasome 
activation as well as for the association with STING in the cytoplasm resulting in IRF-3 phosphorylation, 
nuclear pIRF-3 localization and interferon-β production. Collectively, these comprehensive studies highlight that 
BRCA1 plays a hitherto unidentified immunomodulatory role to facilitate the anti-viral functions of IFI16 and 
acetylation of nuclear IFI16 is a necessary post-translational modification for innate responses during 
herpesvirus infection. These studies open up a new understanding of virus-host interplay, viral genome sensing 
and host innate anti-viral defense mechanisms.  
Abbreviations: IFNs, interferons; PAMPs, Pathogen Associated Molecular patterns; DAMPs, Damage Associated Molecular 
patterns; PRRs, pattern recognition receptors; TLR9, endosomal membrane bound; HIN, hematopoietic expression, 
interferon-inducible nature and nuclear localization; IFI16, interferon-inducible protein 16; EBV, Epstein-Barr virus; HSV-1, 
herpes simplex virus type-1; HCMV, human cytomegalovirus; NLS, nuclear localization signal; DDR, DNA damage 
response; PTM, post-translational modification; HMVEC-d, human microvascular dermal endothelial; PEL, primary effusion 
B-cell lymphoma; STING, stimulator of interferon genes; HFF, human foreskin fibroblast; wt, wild type; P/DAMP, 
pathogen/danger associated molecular pattern; BRCA1, breast cancer tumor suppressor protein; CHX, cycloheximide; GAPs, 
GTPase-activating proteins. 
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Introduction 
The Innate immune system is the front line of host defense 
that detects pathogens via the exogenous PAMPs (Pathogen 
Associated Molecular patterns) and Damaged-self through 
endogenous DAMPs (Damage Associated Molecular patterns) 
to elicit the inflammatory and/or protective responses. 
Detection of PAMPs and/or DAMPs are achieved via the 
germ line encoded cellular surveillance pattern recognition 
receptors (PRRs). A remarkable feature of mammalian cells 
is that they can distinguish self from non-self despite the 
similarities between the PAMPs and equivalent cellular 
molecules. Viral DNA or RNA genomes are recognized by a 
diverse number of host sensors depending upon their 
subcellular localizations and consequently induce DNA- or 
RNA- driven antiviral immune reactions including the 
induction of Type-I interferons (IFNs) and/or 
inflammasomes, production of inflammatory cytokines or 
induction of cell death [1, 2].  
There is a wealth of information available regarding the 
sensors of viral RNA such as RIG-I, MDA5, TLR3, TLR7, 
PKR, RNase L and LGP2. Similarly, significant progress is 
made regarding the sensors of viral DNA and  studies have 
demonstrated the presence of a number of viral DNA sensors 
in the cytoplasm as well as in the nucleus which includes 
TLR9 (endosomal membrane bound), ZBP1/DAI, AIM2, 
DDX-41, DDX-60, DNA-PK, DHX-9, DHX-36, IFI16, 
RNA-polymerase III, LRRFIP1 and cGAS (Table 1) which 
bind to DNA in a sequence-specific or non-sequence-specific 
manner.  
Several in vivo and in vitro studies have demonstrated that 
some of these proteins, known as HIN (hematopoietic 
expression, interferon-inducible nature and nuclear 
localization)-family proteins, play roles in the activation and 
regulation of cellular signaling, culminating in the production 
of IFNs plus IL-1β and IL-18, upon recognition of foreign 
viral DNA via the 200-amino acid HIN domain [3-6].  In 
addition to the HIN domain, the majority of these proteins 
also have a pyrin domain (PYD) and have been grouped in 
the PYHIN family and are also known as absent in 
melanoma 2-like receptors (ALRs). So far, four homologs 
from humans (absent in melanoma 2 [AIM2], gamma 
interferon-inducible protein IFI-16 [IFI16], myeloid cell 
nuclear differentiation antigen [MNDA], and 
interferon-inducible protein X [IFIX]) and 13 homologs from 
mice belonging to the PYHIN family have been identified [7, 
8].  
Herpesviruses establish a latent infection in the nucleus of 
specific cells and reactivation results in the viral dsDNA 
replication and infectious virus production. Similar to the 
important roles played by the cytoplasmic PYHIN proteins in 
intrinsic immunity, nucleus associated interferon-inducible 
protein 16 (IFI16) has emerged as an innate sensor of nuclear 
episomal genomes of herpesviruses such as Kaposi's 
sarcoma-associated herpesvirus (KSHV), Epstein-Barr virus 
(EBV), herpes simplex virus type-1 (HSV-1), and human 
cytomegalovirus (HCMV) resulting in the induction of 
inflammatory cytokines and IFN production, as well as a 
restriction factor against viral transcription and replication [9- 
22]. 
In this research highlight we summarize our key recent 
findings of a) the novel role of cellular BRCA1 protein, a 
DDR repair sensor and transcription regulator, in IFI16’s 
ability to sense the nuclear herpes viral DNA and subsequent 
induction of innate responses, and b) the role of nuclear 
acetylation of IFI16 after viral genome recognition in 
trafficking to the cytoplasm during herpesvirus infection [23, 
24]. 
IFI16 
IFI16 has the following molecular architecture (Figure 1): 
(1) An N-terminal PYD domain involved in homotypic 
protein-protein interactions and/or heterotypic interactions 
with several other cellular proteins including p53, Rb, 
BRCA1, ASC, SP1 and STING [9, 10, 11, 25, 26]. (2) Four 
nuclear localization signal (NLS) motifs. Motif 1 (aa 96-100) 
and motif 2 (aa 127-138) are attributed to nuclear entry after 
synthesis in the cytoplasm [27]. (3) Two DNA binding HIN 
domains (HIN-A and HIN-B). HIN-A is reported to possess 
greater affinity towards DNA than HIN-B. HIN-B can also 
interact with oligonucleotides and oligosaccharides via an 
oligonucleotide-oligosaccharide binding fold (OB-fold) 
which contains two tandem β-barrels [28]. (4) Region in 
between the HIN-A and HIN-B domains consisting of 
several serines, threonines and prolines. The length of this 
region is regulated by alternative mRNA splicing and 
produces three IFI16 isoforms (A-C) [29]. The B-isoform is 
most abundantly expressed in human non-immune 
(endothelial, fibroblasts, epithelial cells) as well as in 
immune (macrophages, B and T cells) cells. 
IFI16 has been shown to participate in a spectrum of 
functions ranging from the DNA damage response (DDR), 
induction of apoptosis and senescence, regulation of cell 
growth and cell differentiation, and as a secreted autoantigen 
in the pathogenesis of autoimmune systemic lupus 
erythematosus disease [30-36].  
Although IFI16 is predominantly a nuclear protein, studies 
such as immunofluorescence, cell fractionation or 
DNA-protein pull downs have shown that a portion of the 
IFI16 pool localizes in the cytoplasm during bacterial or viral  
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Table 1. Viral DNA sensors 
Sensors localization DNA type Virus Immune  response 
pathway 
References 
TLR9 Endosome Unmethylated 
CpG motif 
ADV, HSV1, 
HSV-2, CMV, EBV 
IFN-α, IFN-β via 
MYD88 
[48, 49, 50, 51] 
DAI/ZBP-1 Cytoplasm ds DNA HSV-1, CMV IFN-β via STING; 
Necrosis via RIP3  
[52, 53]  
DHX 36 Cytoplasm Class A CpG motif HSV-1 IFN-α, via MYD88 [54] 
DHX 9 Cytoplasm Class B CpG motif HSV-1 IFN-α, via MYD88 [54] 
DDX41 Cytoplasm ds DNA ADV, HSV-1 IFN-α, IFN-β via STING [55, 56] 
DDX60 Cytoplasm ds DNA HSV-1 IFN-β via RIG-I [57] 
RNA POL III Cytoplasm AT rich ds DNA ADV, HSV-1, EBV IFN-β via RIG-I [58, 59] 
DNA-PK Cytoplasm ds DNA VACV, HSV-1, HSV-2 IFN-β, IFN-γ, IL6 via 
STING 
[60, 61, 62] 
AIM2 Cytoplasm ds DNA ADV, CMV, HBV, HPV-16,  
VACV 
IL-1β, IL-18 via 
inflammasome 
[63, 64, 65, 66] 
IFI16 Nucleus, Cytoplasm ds DNA, ss DNA HSV-1, KSHV, EBV, CMV, 
HIV, VACV 70 mer DNA  
IL-1β, IL-18, IL-33, via 
inflammasome; IFN-β, 
CXCL-5, CXCL-10, 
CXCL-20 via STING 
[12, 13, 14, 16, 23, 24,27, 67]  
IFIX Nucleus, Cytoplasm ds DNA HSV-1, VACV 70 mer DNA unknown [68] 
c-GAS Nucleus, Cytoplasm ds DNA ADV, HSV-1, MAV/VACV 
(modified vaccinia virus) 
IFN-α, IFN-β via STING [46, 69, 70]  
ADV: Adeno virus; CMV: Cytomegalo virus; HBV: Hepatitis B virus; HPV-16: Human papilloma virus -16; HSV-1 and 2: Herpes simplex 
virus-1 and 2; VACV: Vaccinia virus; EBV: Epstein Barr virus; KSHV: Kaposi’s Sarcoma-associated herpes virus. 
infection, in vitro DNA transfection or UV-light treatment [9, 
18, 34, 37, 38]. Interestingly, IFI16-DNA binding may result in 
the activation of different signaling pathways depending on 
the crucial subcellular localization of IFI16 that is influenced 
by interaction with other proteins. Intracellular distribution of 
IFI16 is likely to be associated with its post-translational 
modification (PTM) or primary sequence since treatment of 
IFN-α have been shown to distribute the phosphorylated 
form of p202 and p204 (murine variant of HIN-family 
protein) towards the cytoplasm, nucleoplasm and nucleolus 
[39] . IFI16, which exhibited a predominant cytoplasmic 
localization in a prostate cancer epithelial cell line, has been 
shown to have sequence variability than the predominant 
nuclear IFI16 observed in primary epithelial cell [30]. 
Acetylation at a nuclear localization signal of IFI16 has also 
been shown to restrict it to the cytoplasm instead of nucleus 
[27]. However there is a dearth of knowledge on the kinases, 
acetyl transferases or acetylases and other cellular 
modulators targeting IFI16 for PTMs particularly during 
virus infection and it is therefore important to define how 
these proteins influence IFI16 localization and function. 
Role of IFI16 in sensing herpes viral DNA and innate 
responses 
Whether innate responses recognize and respond to the 
presence of foreign episomal genomes of herpesviruses as 
well as other DNA viruses in the infected cell nuclei leading 
to the induction of inflammatory responses was not known 
until 2011. Our studies revealed that de novo KSHV 
infection of primary human microvascular dermal endothelial 
(HMVEC-d) cells induces IFI16-ASC-procaspase-1 
Figure 1. Schematic representation of human IFI16 structure. Residues 10-83 constitute the N-terminal PYRIN 
domain. 97->143 contain NLS motifs. The solid-blue boxes denote the HIN-A (residues 192-393) and the HIN-B 
(residues 515-710) domains. Oval regions indicate the S/T/P-rich seven amino acid repeat motifs between the two 
HIN domains, resulting from alternative splicing of the gene. The HIN-B domain also contains an 
oligonucleotide/oligosaccharide binding fold. Numbers located above the diagram represent amino acid positions. 
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inflammasome formation in the nucleus and its redistribution 
to the cytoplasm [10]. Colocalization of IFI16 with viral 
genome in the infected endothelial cell nucleus, induction of 
IFI16-ASC inflammasomes by UV-inactivated KSHV and 
the absence of induction by lentivirus vectors expressing 
KSHV genes demonstrated that a) KSHV genes individually 
do not play a role in IFI16-inflammasome activation, b) the 
IFI16-inflammasome is not induced against linear integrated 
foreign DNA, and c) episomal KSHV genome is required for 
IFI16-inflammasome activation.  
Our subsequent studies demonstrated that only the 
IFI16-inflammasome is constitutively induced in KSHV 
latently infected endothelial and primary effusion B-cell 
lymphoma (PEL) cells [12], as well as in B-lymphoma, 
epithelial and lymphoblastoid cells latently infected with 
EBV [13]. Colocalization of IFI16 with the latent KSHV and 
EBV genome in the nuclei suggested that continuous sensing 
of latent genome could be a reason for the constitutive 
inflammasome induction and cytoplasmic relocalization. 
However, the mechanism behind the redistribution was not 
known. In addition, IFI16 has also been shown to interact 
with STING (stimulator of interferon genes) leading to 
phosphorylation and nuclear translocation of IRF3 via the 
IFI16-STING-TBK signaling axis, resulting in IFN-β 
production during HSV-1 infection [9, 16].  
Our studies also revealed that de novo infection of primary 
human foreskin fibroblast (HFF) cells by HSV-1 also induces 
IFI16-ASC-procaspase-1 inflammasome formation in the 
nucleus and its redistribution to the cytoplasm, and the 
association of IFI16 with ASC was limited to 4 h p.i. after 
infection with 1 PFU/cell [14]. IFI16 colocalization with the 
HSV-1 genome at early times post-infection suggested that 
recognition of the viral DNA is probably the driving force for 
IFI16 inflammasome assembly. Consistent with an earlier 
report [16], HSV-1 infection of HFF cells induced the 
proteasomal degradation of IFI16 via HSV-1 immediate 
early ICP0 protein. Although studies by Orzalli et al., 2012 
showed the degradation of IFI16 during HSV-1 infection in 
an ICP0-dependent manner, they did not observe any 
cytoplasmic IFI16 after 4 h of infection. However, 
experiments with fractionated cells infected with wild type 
(wt) HSV-1 were not carried out.  Our immunofluorescence 
studies show that IFI16 exited the nucleus of cells infected 
with mutant d106 and d109 as well as wt HSV-1 but 
translocation was lesser with the mutant viruses than with wt 
HSV-1, which may account for the discrepancy. In addition, 
Orzalli et al., 2012 used a significantly higher MOI of 10 to 
50 PFU/cell than the 1 PFU/cell in our studies, which could 
likely lead to some differences in the kinetics of IFI16 
translocation and not detecting cytoplasmic IFI16 at their 
chosen time points, as at this high MOI, we observed the 
degradation of IFI16 before 4 hrs in the wt HSV-1 infected 
cells. 
Cytosolic sensors like AIM2 and NLRP3 have been 
shown to activate inflammasomes in response to infection by 
bacteria, DNA and RNA viruses. However during latency, 
KSHV and EBV genomes persist in the infected cell nuclei 
without being exposed to these cytosolic sensors. Therefore, 
induction of the inflammasome by latent KSHV suggests 
existence of a pathogen/danger associated molecular pattern 
(P/DAMP) recognition system within the nucleus and our 
studies identify IFI16 as one of the nuclear danger sensing 
receptors. Our studies clearly established that IFI16 forms a 
functional inflammasome in response to KSHV/EBV and 
HSV-1 infection. Silencing IFI16 inhibited inflammasome 
activation without effecting AIM2 or NLRP3 pathways. 
Additionally, results of our immunofluorescence and co-IP 
studies in the cell culture system were strongly supported by 
the colocalization of IFI16 and ASC in KSHV infected PEL 
patient samples [12].  
Failure to detect interaction between ASC and IFI16 by 
some earlier studies could be due to these studies being 
aimed at identifying a protein that can detect cytosolic DNA, 
they used the transfected cytosolic DNA as a trigger to 
examine ASC interaction with IFI16 and other HIN-200 
members. However, none of the stimuli used were located in 
the nucleus, and therefore it is not surprising that nuclear 
IFI16 or other nuclear HIN-200 proteins did not have any 
role in this context. Our studies suggest the requirement for 
an appropriate stimulus in the nucleus. 
Role of IFI16 as a restriction factor for herpesviruses 
IFI16 has been described as a restriction factor for herpes 
viral lytic replication [11, 15, 17]. It restricts HCMV replication 
by displacing transcription factors on E and L but not IE 
gene promoters [11] and restricts HSV-1 replication 
particularly replication of ICP0-deficient HSV-1 [15, 17]. We 
have also recently demonstrated that, independent of its 
innate immune response, IFI16 inhibited HSV-1 replication 
by repressing viral gene expression via its binding to the 
transcription start sites of viral genes, reducing the 
association of transcription factors to these sites and by 
promoting global histone modifications on the viral genome 
[22]. However, questions such as whether pathogen DNA is 
recognized by IFI16 directly or in association with other host 
proteins and how IFI16 differentiates host vs. pathogen DNA 
remain unknown.  
BRCA1 is a component of IFI16-inflammasomes induced 
in herpesvirus (KSHV, EBV, and HSV-1) infected cells 
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Upon entry into the nucleus, the linear epigenetically 
naïve virion-associated herpesviral dsDNA genome 
circularizes, associates with histones and nucleosome 
proteins leading to epigenetic control [40]. The host cell DDR 
acts in a signal cascade event that includes the 
phosphorylation of repair mediators (H2AX, BRCA1, 53BP1, 
and Mdc1) and effectors of the checkpoint responses [CHK1 
(Checkpoint kinase 1) and CHK2 (Checkpoint kinase 2)]. 
The DDR may also recognize exogenous genomes of nuclear 
DNA viruses which manipulate the DDR for their advantage 
[41]. During de novo infection, entry of KSHV DNA into the 
nuclei of endothelial cells induces an immediate DDR 
response of ATM kinase, H2AX, CHK1, CHK2 and BRCA1 
(breast cancer tumor suppressor protein) activation [42]. Since 
IFI16 is believed to be a part of the large BRCA1-associated 
genome surveillance DDR complex (BASC) [43] and is also 
known to form a functional IFI16-ASC-procaspase-1 
inflammasome during KSHV, EBV and HSV-1 infection [10, 
12, 13, 14], we hypothesized that IFI16 forms complexes with 
different proteins to mediate different functions, and that one 
or more of these IFI16 complexes recognizes the KSHV 
DNA to induce an innate inflammasome or interferon 
response.  
Herpesvirus infection induced increased association 
between IFI16 and BRCA1 was observed from our 
coimmunoprecipitation (co-IP) and proximity ligation assay 
(PLA) analyses; however, IFI16 was not associated with 
DDR proteins during virus infection and even in bleomycin 
induced DDR. Hence this interaction is probably distinct 
from the complexes formed by BRCA1, H2AX and CHK2 
proteins during DDR and the IFI16-BRCA1 complex may 
have some different roles during herpesvirus infection.  
We, therefore, asked the questions what is the functional 
implication of this IFI16-BRCA1 association? Does this 
association lead to regulation of IFI16-inflammasome 
activation and/ or innate interferon response during herpes 
infection?  
Interestingly, we did find the association of BRCA1-ASC, 
BRCA1-Caspase-1, BRCA1-IFI16 and IFI16-ASC and their 
cytoplasmic distribution during de novo infection by KSHV 
(HMVEC-d, HFF and peripheral blood monocyte cell 
[PBMC]),  HSV-1 (HFF) and EBV (PBMC) as well as 
latent KSHV [TIVE-LTC (Telomere immortalized vascular 
endothelial-latently infected cell) and PEL (BCBL-1)  and 
EBV [LCL (Lymphoblastoid cell line)] infection in our co-IP 
and PLA studies. In addition, our double sequential PLA also 
demonstrated that BRCA1, IFI16, ASC are present in the 
same molecular complex as we found colocalization of some 
of the BRCA1-IFI16 complex with IFI16-ASC complex and 
some did not colocalize but remained very close to each 
other or were separated. This certainly gives the indication 
that BRCA1 probably is a component of herpesvirus induced 
IFI16-inflammasome complex. 
Since BRCA1 lacks a PYD domain to interact directly 
with the PYD domain of ASC, the similarities of the BRCA1 
association with ASC to that of IFI16 with ASC prompted us 
to investigate whether the BRCA1-ASC interaction requires 
the presence of IFI16. Although ASC was found in BRCA1 
immunoprecipitates from control si-RNA treated KSHV 
infected cells, in contrast, little or no ASC was co-IP-ed with 
BRCA1 in si-IFI16 treated virus infected cells. This result 
suggests that KSHV induced association of BRCA1 (with no 
PYD domain) with inflammasome adaptor ASC (with PYD 
domain) relies on the presence of IFI16. Interestingly, 
BRCA1 was not co-IPed with AIM2 or NLRP3 in uninfected 
or KSHV infected cells which not only demonstrates the 
specific interaction of BRCA1 with IFI16 but also ruled out 
its association with other cytoplasmic inflammasome sensors 
under physiological conditions as well as during KSHV 
infection.  
In contrast to the nuclear replicating herpesvirus infected 
cells, in cells infected with vaccinia virus replicating its 
dsDNA in the cytoplasm of infected cells, we observed the 
activation of the cytoplasmic AIM2-ASC inflammasome 
instead of the IFI16-ASC inflammasome and no significant 
change in the association of BRCA1 and IFI16 which 
suggests that the presence of nuclear viral DNA is probably 
necessary for increased BRCA1-IFI16 interactions, 
association with ASC and their cytoplasmic redistribution. 
BRCA1 is essential for IFI16-inflammasome induction 
and cytoplasmic distribution during herpesvirus (KSHV, 
EBV, and HSV-1) infection 
To understand the role of BRCA1 in IFI16-inflammasome 
activation, we assessed the association of IFI16 (sensor), 
ASC (adaptor) and caspase-1 (executor) in BRCA1 
knockdown (by si-RNA) or BRCA1 null cells (HCC-1937) 
upon virus (KSHV and HSV-1) infection. Surprisingly, in 
virus infected si-control or BRCA1 positive cells (184b5) 
interaction among IFI16, ASC and caspase-1 and their 
cytoplasmic distribution was prominent but very little or no 
association and cytoplasmic distribution was observed in the 
absence of BRCA1 from our co-IP and PLA analyses. As 
expected, cleaved caspase-1 and mature IL-1β and secreted 
IL-1β were observed in BRCA1 positive cells but not present 
in detectable levels or at very low levels in BRCA1 
knockdown conditions or the absence of BRCA1. 
Additionally, when we transduced BRCA1- HCC cells with 
lentiviruses expressing BRCA1 or control lentiviruses the 
presence of cleaved caspase-1 and mature IL-1β was clearly 
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seen in BRCA1 expressing but not in BRCA1 negative cells 
during either the early or late period post-KSHV infection. 
Together, these results demonstrate the active participation of 
BRCA1 in the assembly and cytoplasmic trafficking of 
IFI16-ASC-caspase-1 inflammasomes and formation of 
functionally active caspase-1 and mature IL-1β during 
KSHV and HSV-1 infection (Figure 2). 
BRCA1 is necessary for IFI16-STING mediated Type-I 
interferon response during herpesvirus infection 
Because a fraction of IFI16-BRCA1 complexes did not 
colocalize with IFI16-ASC in our sequential PLA 
experiments we set out to investigate the role of BRCA1 in 
the other arm of the IFI16-mediated innate response namely 
type-I interferon production. Compared to the si-control or 
BRCA1 positive cells where there was a gradual increase in 
IFN-β secretion (via IFN-β ELISA) and then a decrease 
during KSHV or HSV-1 course of infections, BRCA1 
knockdown or absence resulted in significant decrease in 
secreted IFN-β levels even during virus infection. The reason 
behind this observation was revealed from the studies where 
association of IFI16 with STING (from PLA analysis), 
responsible for the initial signal cascade for IFN-β, was 
found to be abrogated in the absence of BRCA1 and was 
subsequently reflected from the very low level of 
phosphorylation of downstream signal molecule IRF3 
followed by its lower nuclear translocation (from western 
blot and IFA analysis). Together, these results clearly 
highlighted the essential role of BRCA1 in the regulation of 
IFI16 mediated host innate responses of induction of IFN-β 
during herpesvirus infection (Figure 3). 
BRCA1 is involved in herpesvirus genome recognition by 
IFI16 during de novo infection  
From our observations that (a) BRCA1 associates with 
IFI16 and ASC and undergoes cytoplasmic translocation as a 
part of the IFI16 inflammasome complex during de novo 
KSHV, EBV, HSV-1 as well as latent KSHV and EBV 
infections, (b) presence of nuclear viral genome is required 
for increased BRCA-IFI16 and IFI16-ASC interactions, and 
(c) absence of BRCA1 impairs IFI16 cytoplasmic 
translocation, IFI16 inflammasome assembly and activation 
and IFI16-STING signalosome dependent IFN-β production, 
we hypothesized that IFI16, although, reported to directly 
bind DNA in an artificial system [5], in the dynamic nuclear 
environment during virus infection probably requires 
BRCA1 for sensing/recognizing nuclear viral DNA  
followed by the subsequent innate response. Indeed from the 
PLA-IFA studies we observed a considerable level of IFI16 
or BRCA-IFI16 complex colocalized with EdU (5’ Ethynyl, 
2’ deoxy uridine)-labelled KSHV and HSV-1 genomes. In 
contrast, BRCA1 knockdown or absence resulted in a notable 
decrease in IFI16-viral DNA colocalization and its 
cytoplasmic distribution. Further biochemical analysis 
following EdU-HSV-1 infection in si-control and si-BRCA1 
pretreated HFF cells, protein-DNA cross-linking, chromatin 
shearing, biotin-TEG azide tagging to EdU via Click reaction 
and capturing of biotin-tagged Edu-chromatin fragments of 
HSV-1 genome on streptavidin beads, the presence of virus 
genome associated IFI16 was observed from eluted proteins 
of streptavidin captured genome from si-control cells. In 
contrast, significantly less IFI16 was detected from the EdU 
genome pull down fraction from si-BRCA1 treated virus 
infected cells. Overall, these data clearly demonstrated the 
involvement of BRCA1 in herpesvirus nuclear genome 
recognition by IFI16 and subsequent cytoplasmic 
distribution.  
Differential subcellular distribution of IFI16 upon herpes 
virus infection 
Figure 2. BRCA1 is necessary for herpes virus infection induced IFI16 inflammasome assembly and 
activation. BRCA1 knockdown or absence abrogates IFI16-mediated recognition of herpes virus genome and 
subsequent IFI16-ASC-Caspase-1 inflammasome assembly, its cytoplasmic translocation and Il-1β production 
during herpes virus infection. 
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Although IFI16, a predominantly nuclear protein, acts as a 
nuclear DNA sensor of KSHV, EBV, HSV-1 and HCMV1 
DNA genome and undergoes (some fraction of total pool) 
relocalization to the cytoplasm for the induction of innate or 
intrinsic antiviral responses, the molecular mechanism 
regulating this intracellular distribution was unknown. It 
could likely be associated with its PTMs, since, the presence 
of phosphorylated IFI16 has been observed in the cytoplasm 
early during HCMV infection [38] and acetylation at nuclear 
localization signal of IFI16 (Lys 99 and Lys 128) has been 
shown to restrict it to the cytoplasm instead of the nucleus [27]. 
However information regarding any kinases, acetyl 
transferases or acetylases and other cellular modulator 
proteins responsible for IFI16 PTMs particularly during virus 
infection was lacking. In our concurrent studies, we for the 
first time have demonstrated that the presence of KSHV 
genome in the nucleus induces p300 mediated acetylation of 
nuclear IFI16 followed by its Ran-GTPase assisted 
cytoplasmic translocation and this acetylation is required for 
IFI16-ASC inflammasome assembly and IFI16-STING 
signalosome activation. We theorized that acetylation of 
IFI16 could be one of the reasons for cytoplasmic transport 
since acetylation of HMGB-1 (high-mobility group protein 
B1) protein involved in transcription/ chromatin bending has 
been shown to result in HMGB-1’s translocation into the 
cytoplasm [44]. However, the fate of IFI16 during nuclear 
DNA sensing was not studied. 
Acetylation inhibitor interfere with IFI16’s nucleus to 
cytoplasmic distribution during herpesvirus infection 
Analysis of the kinetics of IFI16 acetylation by IP-d with 
anti-acetyl lysine antibody followed by western blotting in 
the nuclear and cytoplasmic fraction of KSHV infected 
HMVEC-d cells demonstrated the presence of acetylated 
cytoplasmic IFI16 as early as 30 min p.i. which steadily 
increased during the observed 24 h p.i.. Based on the earlier 
report that the cellular transcriptional coactivator protein 
p300, which functions as a histone acetyltransferase, has 
been involved in the cytoplasmic acetylation of IFI16’s NLS 
domains [27], we used p300 competitive inhibitor C-646 (with 
least toxic 1μM concentration  that did not interfere viral 
entry or nuclear viral genome delivery) and analyzed IFI16 
acetylation and  nuclear/cytoplasmic distribution during de 
novo KSHV and HSV-1 infected primary cells as well as 
KSHV and EBV latently infected cell lines via co-IP and 
PLA. A Significant increase in IFI16 acetylation was 
observed in KSHV, HSV-1 de novo infected HMVEC-d and 
HFF cells respectively as well as KSHV latently infected 
BCBL-1 and EBV latently infected Raji (latency-I) and LCL 
(latency-III) cell lines than uninfected or KSHV negative 
BCBL-1 or EBV negative Ramos cell lines. In contrast, 
treatment with C-646 substantially decreased the IFI16 
acetylation and cytoplasmic distribution. However, use of 
vaccinia virus infection (replicating dsDNA exclusively in 
the cytoplasm) did not significantly increase IFI16 
acetylation and cytoplasmic localization and replication 
incompetent UV-treated KSHV (UV-KSHV) infection which 
also delivers the viral DNA to the nucleus also induced 
IFI16-acetylation and cytoplasmic distribution. These results 
suggested that p300 mediated acetylation of IFI16 may drive 
its cytoplasmic localization during herpes virus infection and 
it requires the presence of nuclear herpesvirus genome but 
not necessary for the virus to be replication competent.  
The p300 HAT assay and HDAC assay performed with 
nuclear and cytoplasmic fractions of KSHV infected 
HMVEC-d cells and treatment with their respective specific 
inhibitors revealed increased p300 activity in the nucleus but 
not in the cytoplasm, thus supporting our conclusion that 
p300 acetylates IFI16 in the nucleus after viral genome entry 
into the nucleus. Simultaneously, the increased activity of 
HDAC, further demonstrates that the increase in acetylation 
was not due to the activity of HDACs but due to p300. 
Interestingly, from the PLA study with anti-BrdU and 
ant-IFI16 antibodies to check nuclear colocalization between 
Figure 3. BRCA1 is necessary for IFI16-STING mediated Interferon response. BRCA1 knockdown or 
absence decreases IFI16-STING signalosome activation, phosphorylation of IRF3 and its nuclear 
translocation and IFN-β production during herpes virus infection. 
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KSHV/HSV-1 BrdU labelled genome and IFI16 
demonstrated no significant changes in IFI16-genome 
colocalization even in the presence of C-646. Similarly, 
IFI16-CHIP assay of KSHV positive BCBL-1 cells with or 
without C-646 showed no major differences in binding of 
IFI16 with KSHV genome. These results suggested that a) 
IFI16 directly associates with KSHV and HSV-1 genomes, 
and b) the acetylation of IFI16 is not obligatory for genome 
recognition. 
Acetylation inhibitor impedes Ran-GTP dependent IFI16 
transport from nucleus to cytoplasm and leptomycin 
hinders nuclear export of IFI16 
The dynamic process of exporting molecules of >50-kDa 
from the nucleus is initiated by exportins binding to cargo 
and Ran-GTP protein. The guanine-nucleotide exchange 
factor (GEF) of Ran that converts Ran-GDP to the GTP form 
is in the nucleus and GTPase-activating proteins (GAPs) for 
Ran-GTPase are present in the cytoplasm as well as on the 
cytoplasmic face of the nuclear pore. To determine whether 
Ran is responsible for IFI16 transport from the nucleus to the 
cytoplasm and the role of acetyl transferase inhibitor C-646 
on this event we performed co-IP or PLA to analyze 
IFI16-Ran association in the presence or absence of C-646 in 
KSHV infected HMVEC-d cells (4h). Both studies showed 
increased association of the IFI16 with Ran which was 
significantly decreased during C-646 treatment suggesting 
that acetylation enhances the association of IFI16 with 
Ran-GTP during virus infection which could be facilitating 
IFI16 cytoplasmic transport.  
Previous in vitro studies suggested that acetylation of 
IFI16 NLS domain stabilizes its cytoplasmic retention and 
restricts its nuclear movement [27]. However, to determine 
whether the cytoplasmic IFI16 detected during KSHV de 
novo infection and latency represents newly synthesized 
IFI16 or redistributed from the nucleus, we used 50nM 
Leptomycin B (LPT) to block nuclear export to the 
cytoplasm. Indeed, LPT treatment abolished KSHV induced 
IFI16 cytoplasmic distribution although blocking of nuclear 
IFI16 export by LPT did not affect nuclear IFI16 acetylation 
or IFI16-inflammasome formation since no detectable 
changes were observed in the level of acetylated-IFI16 or 
IFI16-ASC association or caspase-1 cleavage. Interestingly, 
in the presence of cycloheximide (CHX), that blocks protein 
synthesis, a similar level of cytoplasmic IFI16 was seen in 
virus infected cells which ruled out the possibility that 
detection of acetylated IFI16 is due to accumulation of newly 
synthesized IFI16 in the cytoplasm. Taken together, these 
results demonstrated that a) blocking nuclear export by LPT 
did not interfere with the acetylation of IFI16, formation of 
IFI16-ASC complex or activation of caspase-1, b) blocking 
protein synthesis by CHX did not affect the cytoplasmic 
distribution of IFI16 from the nucleus, and c) the increased 
level of IFI16 in the cytoplasm in the infected cells was due 
to its redistribution from the nucleus and not due to newly 
translated cytoplasmic IFI16. 
Inhibition of IFI16 acetylation impairs induction of the 
IFI16 innate inflammasome and interferon response 
during herpesvirus infection 
Keeping in view of the similar pattern between acetylated 
IFI16 distribution and inflammasome activation in virus 
infected cells, we determined the correlation of IFI16 
acetylation and inflammasome activation during de novo 
KSHV infection as well as KSHV latently infected cells. 
Both PLA and co-IP analysis detected prominent association 
between inflammasome sensor IFI16 and adaptor ASC in 
untreated virus infected cells, whereas, C-646 treatment 
significantly reduced such interaction. In addition, infection 
induced aggregation of IFI16, a trigger to the initiation of 
IFI16 inflammasome activation, was also compromised due 
to treatment of acetylation inhibitor C-646. Effect of 
acetylation inhibitor was further reflected to the downstream 
Figure 4. Acetylation of IFI16 is critical for IFI16-inflammasome assembly and activation. 
Inhibition of IFI16 acetylation restricts formation of the IFI16-ASC-Caspase-1 inflammasome complex 
and subsequent production of IL-1β. 
 
Inflammation & Cell Signaling 2015; 2: e1076. doi: 10.14800/ics.1076; ©  2015 by Dipanjan Dutta, et al. 
http://www.smartscitech.com/index.php/ics 
 
Page 9 of 13 
 
signal as we observed a very low level of cleaved caspase-1 
and cleaved/mature IL-1β and IL-33 in KSHV infected cells 
compared to untreated virus infected cells. A Similar effect 
was also observed in p300 knockdown (si-RNA mediated) 
cells.  
These results confirmed that acetylation of IFI16 promotes 
functional inflammasome assembly and activation (Figure 4). 
However, ASC knockdown did not result in detectable 
changes in overall IFI16 acetylation, although the 
cytoplasmic fraction of acetylated IFI16 was slightly reduced 
suggesting that ASC is dispensable for IFI16 acetylation 
which probably takes place prior to inflammasome formation 
and the IFI16-ASC inflammasome contributes to a portion of 
the IFI16 detected in the cytoplasm but inflammasome 
independent cytoplasmic distribution of IFI16 may be 
attributed to export alone or in complex with other protein(s).   
With little or no information regarding post-translational 
modifications of IFI16 (such as acetylation) regulating virus 
induced interferon (IFN) response, we further analyzed the 
role of IFI16 acetylation in IFI16-STING-signalosome 
mediated IFN-β production during KSHV and HSV-1 
infection although earlier reports suggest moderate IFN-β 
induction during de novo KSHV and HSV-1 infection and 
early lytic and/or latent gene products interfere with this 
response at latter times post infection [9, 16, 18, 22, 45]. At 4h post 
KSHV or 6h post HSV-1 de novo infection, IFN-β was 
detected by ELISA from the infected cell supernatant, which 
was significantly (> 3-4 folds) reduced upon C-646 treatment. 
Furthermore, IP, WB and IFA analysis showed the 
abrogation of IFI16-STING association, subsequent 
significant reduction of p-IRF3 and its nuclear localization as 
a result of treatment of acetylation inhibitor. However, 
STING knockdown had no effect on IFI16 acetylation 
implying that IFI16 acetylation is upstream to STING 
signalosome activation. Collectively, these studies 
unequivocally demonstrate that IFI16-acetylation is crucial 
for host antiviral IFI16-STING mediated IFN-β induction 
during herpesvirus early infection (Figure 5).  
Overall, these comprehensive studies shed light into the so 
far unresolved question and highlight that (a) IFI16 
acetylation occurs as a dynamic post-genome recognition 
event, and (b) post-acetylation, IFI16 probably moves away 
from the genome for the formation of its complexes and 
eventually leading to its cytoplasmic translocation. 
Conclusions 
The interesting and exciting avenues of viral-DNA sensing 
and the appearance of a number of viral DNA sensors with 
their associated host defense pathways have certainly 
expanded the emerging field; however mechanisms of many 
of their functions are still to be elucidated. For example, 
recent studies suggested that IFI16 and cGAS interact with 
each other and work together in the same signaling cascade 
during HSV-1 infection where IFI16 appears to be stabilized 
by cGAS although IFI16 seems to be the primary DNA 
sensor [46]. However, whether this interaction occurs in the 
nucleus or in the cytoplasm and the kinetics of such 
association after nuclear viral genome recognition remains to 
be determined. In addition, how the message of nuclear viral 
genome sensing by IFI16 in the presence of nuclear cGAS is 
transmitted to the cytoplasm for STING-signalosome 
activation is not clear.  
Similar to AIM2, where an auto inhibited intramolecular 
complex state mediated by PYD and HIN domain interaction 
is liberated upon DNA binding, it could be possible that 
BRCA1 association to the PYD domain of IFI16 [26] could be 
liberating its auto inhibited complex state facilitating the HIN 
domains to sense viral genomes. The protective immune 
response triggered by the detection of microbial effectors 
termed “effector triggered immunity (ETI)” enables the host 
to distinguish pathogens from non-pathogen [2, 47] and this is 
Figure 5. Acetylation of IFI16 is essential for IFI16-STING mediated Interferon beta response. 
Inhibition of IFI16 acetylation hinders IFI16-STING association, IRF3 phosphorylation and its nuclear 
translocation to produce IFN-β during herpes virus infection. 
 
Inflammation & Cell Signaling 2015; 2: e1076. doi: 10.14800/ics.1076; ©  2015 by Dipanjan Dutta, et al. 
http://www.smartscitech.com/index.php/ics 
 
Page 10 of 13 
 
probably of relevance in non-professional immune cells too, 
such as epithelial, endothelial and other cells that come in 
contact with pathogens at different in vivo sites, including at 
the portal of pathogen entry. Our studies demonstrating that 
IFI16-BRCA1 functions as an innate sensor of KSHV, EBV 
and HSV-1 genomes in non-immune professional cells, such 
as endothelial, epithelial and fibroblast cells, and in 
B-lymphoma cell lines as well as the IFI16 and ASC 
interactions in tissue sections from PEL and KS patients [12], 
clearly suggest that these cells have evolved to respond to 
danger signals.  
In addition, (i) association of IFI16 with latent 
chromatinized KSHV and EBV genomes, (ii) continuation of 
viral latent gene expression in the presence of IFI16 and 
IFI16-inflammasomes [12, 13], (iii) IFI16’s ability to mediate 
global differences in HSV-1 genome chromatin 
modifications [17, 22], and (iv) the binding of IFI16 to the 
KSHV gene promoters in latently infected cells as detected 
in our ongoing studies, we theorize that IFI16 has very 
complex roles in gene regulation and there may be other 
factors involved in IFI16’s ability to discriminate foreign vs. 
host DNA. Similar to the IFI16-BRCA1 complex involved in 
pathogen DNA recognition, inflammasome induction and 
IFN-β production shown here, it is possible that IFI16 could 
be forming distinct complexes with different proteins and 
each complex could be mediating distinct functions, such as 
transcription and other responses, which may differ between 
various virus nuclear lytic and latent infections and as per 
host cell types. Determining these possibilities and 
Figure 6. Schematic model for the proposed BRCA1-mediated herpes viral DNA genome 
sensing by IFI16 and post-genome recognition IFI16 acetylation in innate inflammasome as 
well as interferon responses. Following viral DNA entry into the nucleus (1 and 2) 
sequence-independent sensing of viral DNA by the DNA binding HIN-domain of IFI16 likely needs a 
pre-existing complex with BRCA1 via association with the PYD domain of IFI16, which predisposes 
IFI16 as a dedicated viral DNA sensor (innate sensing state), leading to IFI16 mediated innate 
immune activation, one arm of which results in IFI16-ASC-Caspase-1 inflammasome assembly and 
activation (3–7) while the other arm initiates cytoplasmic  IFI16-STING-immune signaling, IRF3 
phosphorylation and nuclear translocation resulting in IFN-β/type I IFN induction (i-viii). Nuclear IFI16 
also undergoes post-genome recognition dependent acetylation by histone acetyl transferase p300 
(4), facilitating ASC-caspase-1 association for inflammasome complex formation (5) and subsequent 
cytoplasmic translocation via Ran-GTP (6). Cytoplasmic distribution of acetylated IFI16 in one way 
induces inflammasomes by caspase-1 activation (7) followed by mature IL-1β production (8-9) and in 
the other way activates STING-signalosome dependent IFN-β production (i- viii). Use of p300 
inhibitor C-646 and knockdown of p300 does not inhibit the ability of IFI16 to recognize the episomal 
viral DNA but impairs the acetylation of IFI16. Leptomycin B (LPT) treatment abrogates acetylated 
IFI16 translocation to the cytoplasm. 
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deciphering whether BRCA1 plays a role in IFI16’s ability to 
influence viral promoters and in the nuclear life cycles of 
DNA viruses requires further extensive studies.  
Furthermore, there is limited information regarding the 
role of PTMs and the mediators of PTMs on the activation or 
inhibition of protein-DNA and protein-protein interactions 
and downstream immune signaling pathways during virus 
infection. Our concomitant study on IFI16-PTM suggests 
that post-genome recognition IFI16 acetylation in the nucleus 
by histone acetyl transferase p300 is necessary for 
IFI16-mediated innate response during herpes virus infection. 
However, why the IFI16-p300 interaction increases in the 
presence of herpes viral DNA and whether IFI16 recruits 
p300 directly or via its interaction with other proteins needs 
to be evaluated further. Although phosphorylation, 
acetylation and ubiquitination have been reported to 
modulate DNA sensing pathways, other PTMs are likely to 
play critical roles in the immune response and which of the 
site/s or domain/s undergo modifications during viral 
genome recognition needs to be examined further. Since 
IFI16 has also been suggested to act as a viral transcriptional 
repressor during HCMV and HSV-1 infection whether the 
regulatory functions of these genes are dependent or 
independent of acetylation or other PTMs need to be 
determined.  
Given the ubiquitous expression of many of these DNA 
binding proteins and the significant potential for endogenous 
DNA to engage these molecules, it is important that DNA 
recognition is tightly regulated.  It becomes increasingly 
necessary to understand their possible coordinated or 
redundant functions and how these immune signaling 
pathways are regulated depending upon cell type variability 
where one or multiple pathways could be active. In view of 
our concurrent studies which enlighten the crucial role of 
BRCA1 as a cofactor regulating viral DNA sensing of IFI16 
and p300 mediated IFI16 acetylation as a post-genome 
recognition event (Figure 6) a broader impact could be 
envisioned in terms of other DNA sensors and their possible 
PTMs in other host-virus interactions and subsequent innate 
or intrinsic responses. Additional studies with increasing 
implementation of modern new technologies will certainly 
provide better understanding of the molecular mechanisms of 
BRCA1 and IFI16 along with other DNA sensors and the 
role of PTMs in the fundamental relation between DNA 
sensing and antiviral response, viral and host genome 
regulation and the dynamic nature of protein interactions 
during infection for future viral intervention strategies. 
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